Skip to main content
. 2017 May 18;56(11):1287–1301. doi: 10.1007/s40262-017-0546-0

Fig. 2.

Fig. 2

Relationship between linear clearance (CLL), non-linear clearance (CLNL), and total clearance (CLtotal) of vedolizumab